Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction.

Abstract:

:Endothelial progenitor cell (EPC) mobilization has been reported following tissue damage, whereas no data are available regarding the mobilization of hematopoietic progenitor cells (HPCs). We performed the phenotypic and functional analysis of circulating CD34+ progenitor cells in patients with acute myocardial infarction (AMI), assessed from admission up to 60 days, in patients with stable angina pectoris (SA), and in healthy controls (CTRLs). In patients with AMI at admission (T0), the number of circulating CD34+ cells was higher (P < .001) than in CTRLs and became comparable with CTRLs within 60 days. Both the number of CD34+ cells coexpressing CD33, CD38, or CD117 and the number of HPCs was higher (P < .02 for all) in patients with AMI at T0 than in CTRLs, as was the number of hematopoietic colonies (P < .03). Patients with AMI (T0) had a significantly increased number of CD34+ vascular endothelial growth factor receptor 2-positive (VEGFR-2+) cells (P < .002) with respect to CTRLs, including CD34(+) CD133(+)VEGFR-2+ and CD34+ CD117(+)VEGFR-2+ EPCs. The number of endothelial colonies was higher in patients with AMI (T0) than in CTRLs (P < .05). No significant difference was documented between patients with SA and CTRLs. Spontaneous mobilization of both HPCs and EPCs occurs within a few hours from the onset of AMI and is detectable until 2 months.

journal_name

Blood

journal_title

Blood

authors

Massa M,Rosti V,Ferrario M,Campanelli R,Ramajoli I,Rosso R,De Ferrari GM,Ferlini M,Goffredo L,Bertoletti A,Klersy C,Pecci A,Moratti R,Tavazzi L

doi

10.1182/blood-2004-05-1831

subject

Has Abstract

pub_date

2005-01-01 00:00:00

pages

199-206

issue

1

eissn

0006-4971

issn

1528-0020

pii

2004-05-1831

journal_volume

105

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis.

    abstract::Perfluorocarbons have shown promise as clinical blood substitutes. Although early experience in Japan with one such product--Fluosol-DA--has been uncomplicated, we observed an adverse pulmonary reaction in the first American patient to receive it and know of similar reactions in two other Americans so treated. Postula...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Vercellotti GM,Hammerschmidt DE,Craddock PR,Jacob HS

    更新日期:1982-06-01 00:00:00

  • Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells.

    abstract::Glucocorticoids are keystone drugs in the treatment of childhood acute lymphoblastic leukemia (ALL). To get more insight in signal transduction pathways involved in glucocorticoid-induced apoptosis, Affymetrix U133A GeneChips were used to identify transcriptionally regulated genes on 3 and 8 hours of prednisolone expo...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2006-11-056366

    authors: Tissing WJ,den Boer ML,Meijerink JP,Menezes RX,Swagemakers S,van der Spek PJ,Sallan SE,Armstrong SA,Pieters R

    更新日期:2007-05-01 00:00:00

  • Cell-cycle-dependent regulation of erythropoietin receptor gene.

    abstract::To understand the regulatory mechanism of erythropoietin (EPO) receptor (EPOR) gene expression, the effect of EPO on the steady-state level of EPOR mRNA was examined using the human EPO-dependent cell line UT-7 as a model system. We found that the treatment of UT-7 cells with EPO resulted in a transient decrease of th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Komatsu N,Kirito K,Kashii Y,Furukawa Y,Kikuchi J,Suwabe N,Yamamoto M,Miura Y

    更新日期:1997-02-15 00:00:00

  • Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo.

    abstract::Primitive chronic myeloid leukemia cells display a unique autocrine interleukin 3 (IL-3)/granulocyte-colony-stimluating factor (G-CSF) mechanism that may explain their abnormal proliferation and differentiation control. Here we show that BCR-ABL transduction of primitive Sca-1(+) lin(-) mouse bone marrow (BM) cells ca...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-05-1324

    authors: Jiang X,Ng E,Yip C,Eisterer W,Chalandon Y,Stuible M,Eaves A,Eaves CJ

    更新日期:2002-11-15 00:00:00

  • Intrathymic progenitor cell transplantation across histocompatibility barriers results in the persistence of early thymic progenitors and T-cell differentiation.

    abstract::Donor hematopoietic stem cells (HSCs) can correct T-cell deficiencies in patients with severe combined immunodeficiency by replacing resident thymus cells. However, as those progenitors that naturally migrate to the thymus are not capable of supporting long-term thymopoiesis, a successful transplant is thought to requ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-08-447417

    authors: de Barros SC,Vicente R,Chebli K,Jacquet C,Zimmermann VS,Taylor N

    更新日期:2013-03-14 00:00:00

  • Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.

    abstract::The outcome of patients with acute myeloid leukemia who are older than 60 years has remained poor because of unfavorable disease characteristics and patient-related factors. The randomized German-Austrian AML Study Group 06-04 protocol was designed on the basis of in vitro synergistic effects of valproic acid (VPA) an...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2013-12-546283

    authors: Tassara M,Döhner K,Brossart P,Held G,Götze K,Horst HA,Ringhoffer M,Köhne CH,Kremers S,Raghavachar A,Wulf G,Kirchen H,Nachbaur D,Derigs HG,Wattad M,Koller E,Brugger W,Matzdorff A,Greil R,Heil G,Paschka P,Gaidzik

    更新日期:2014-06-26 00:00:00

  • Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit.

    abstract::Signaling through the receptor tyrosine kinase kit controls proliferation and differentiation of hematopoietic precursor cells and mast cells. Somatic point mutations of the receptor that constitutively activate kit signaling are associated with mastocytosis and various hematopoietic malignancies. We generated a Cre/l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-11-189605

    authors: Gerbaulet A,Wickenhauser C,Scholten J,Peschke K,Drube S,Horny HP,Kamradt T,Naumann R,Müller W,Krieg T,Waskow C,Hartmann K,Roers A

    更新日期:2011-02-10 00:00:00

  • Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI.

    abstract::Graft-versus-host disease (GVHD) is a prominent barrier to allogeneic hematopoietic stem cell transplantation (AHSCT). Definitive diagnosis of GVHD is invasive, and biopsies of involved tissues pose a high risk of bleeding and infection. T cells are central to GVHD pathogenesis, and our previous studies in a chronic G...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005770

    authors: Assmann JC,Farthing DE,Saito K,Maglakelidze N,Oliver B,Warrick KA,Sourbier C,Ricketts CJ,Meyer TJ,Pavletic SZ,Linehan WM,Krishna MC,Gress RE,Buxbaum NP

    更新日期:2021-01-07 00:00:00

  • Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia.

    abstract::The effect of hydroxyurea in 35 patients with chronic granulocytic leukemia (CGL), who either had entered an accelerated phase of the disease or had experienced excessive myelosuppression following alkylating agents, was studied. By either intravenous or oral administration, the drug was successful in reducing periphe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schwartz JH,Cannellos GP

    更新日期:1975-07-01 00:00:00

  • High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia.

    abstract::Hairy cell leukemia (HCL) is frequently associated with severe pancytopenia. The authors detected high levels of tumor necrosis factor (TNF)-alpha in the bone marrow serum of patients with HCL and found anti-TNF-alpha neutralizing monoclonal antibodies (MoAbs) to be able to enhance hematopoiesis of HCL patients in in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lindemann A,Ludwig WD,Oster W,Mertelsmann R,Herrmann F

    更新日期:1989-03-01 00:00:00

  • Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.

    abstract::We recently identified aberrant cytoplasmic expression of nucleophosmin (NPM) as the immunohistochemical marker of a large subgroup of acute myeloid leukemia (AML) (about one-third of adult AML) that is characterized by normal karyotype and mutations occurring at the exon-12 of the NPM gene. In this paper, we have elu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-11-4745

    authors: Falini B,Bolli N,Shan J,Martelli MP,Liso A,Pucciarini A,Bigerna B,Pasqualucci L,Mannucci R,Rosati R,Gorello P,Diverio D,Roti G,Tiacci E,Cazzaniga G,Biondi A,Schnittger S,Haferlach T,Hiddemann W,Martelli MF,Gu W,

    更新日期:2006-06-01 00:00:00

  • DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells.

    abstract::The Y chromosome encodes male-specific minor histocompatibility (H-Y) antigens that stimulate T- and B-lymphocyte responses after sex-mismatched allogeneic hematopoietic cell transplantation (HCT). A CD8(+) cytotoxic T lymphocyte (CTL) clone that recognizes a novel HLA-B*2705-restricted H-Y antigen encoded by the DDX3...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-06-096313

    authors: Rosinski KV,Fujii N,Mito JK,Koo KK,Xuereb SM,Sala-Torra O,Gibbs JS,Radich JP,Akatsuka Y,Van den Eynde BJ,Riddell SR,Warren EH

    更新日期:2008-05-01 00:00:00

  • Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34.

    abstract::In T cell malignancy, rearrangements of chromosome 14 have been observed with a break in the band that contains the alpha chain gene for the T cell receptor (TCR). Because the beta chain TCR gene is in chromosome band 7q34, we searched for and report finding specific rearrangements of 7q34 exclusively in T cell malign...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Smith SD,Morgan R,Gemmell R,Amylon MD,Link MP,Linker C,Hecht BK,Warnke R,Glader BE,Hecht F

    更新日期:1988-02-01 00:00:00

  • RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses.

    abstract::The receptor for hyaluronic acid-mediated motility (RHAMM) is an antigen eliciting both humoral and cellular immune responses in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and multiple myeloma (MM). We initiated a phase 1 clinical trial vaccinating 10 patients with R3 (ILSLELMKL), a hi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-07-099366

    authors: Schmitt M,Schmitt A,Rojewski MT,Chen J,Giannopoulos K,Fei F,Yu Y,Götz M,Heyduk M,Ritter G,Speiser DE,Gnjatic S,Guillaume P,Ringhoffer M,Schlenk RF,Liebisch P,Bunjes D,Shiku H,Dohner H,Greiner J

    更新日期:2008-02-01 00:00:00

  • Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.

    abstract::The ex vivo expansion of hematopoietic progenitors is a promising approach for accelerating the engraftment of recipients, particularly when cord blood (CB) is used as a source of hematopoietic graft. With the aim of defining the in vivo repopulating properties of ex vivo-expanded CB cells, purified CD34(+) cells were...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Guenechea G,Segovia JC,Albella B,Lamana M,Ramírez M,Regidor C,Fernández MN,Bueren JA

    更新日期:1999-02-01 00:00:00

  • Preclinical efficacy of humanized, non-FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemia.

    abstract::T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy that accounts for ∼20% of ALL cases. Intensive chemotherapy regimens result in cure rates >85% in children and <50% in adults, warranting a search of novel therapeutic strategies. Although immune-based therapies have tremendously improved the trea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003801

    authors: Tran Quang C,Zaniboni B,Humeau R,Lengliné E,Dourthe ME,Ganesan R,Singh S,Scheer JM,Asnafi V,Ghysdael J

    更新日期:2020-09-10 00:00:00

  • Repression of transcription from the human T-cell leukemia virus type I long terminal repeat and cellular gene promoters by wild-type p53.

    abstract::Human T-cell leukemia virus type-I (HTLV-I), the etiologic agent of adult T-cell leukemia (ATL) transforms human T cells both in vivo and in vitro. However, the long latency period between infection and development of ATL, as well as the small fraction of the infected population that actually develops this disease, su...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mori N,Kashanchi F,Prager D

    更新日期:1997-12-15 00:00:00

  • Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease.

    abstract::Pain is the leading cause of emergency department visits, hospitalizations, and daily suffering in individuals with sickle cell disease (SCD). The pathologic mechanisms leading to the perception of pain during acute RBC sickling episodes and development of chronic pain remain poorly understood and ineffectively treate...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-327429

    authors: Hillery CA,Kerstein PC,Vilceanu D,Barabas ME,Retherford D,Brandow AM,Wandersee NJ,Stucky CL

    更新日期:2011-09-22 00:00:00

  • Expression of the Fanconi anemia group A gene (Fanca) during mouse embryogenesis.

    abstract::About 80% of all cases of Fanconi anemia (FA) can be accounted for by complementation groups A and C. To understand the relationship between these groups, we analyzed the expression pattern of the mouse FA group-A gene (Fanca) during embryogenesis and compared it with the known pattern of the group-C gene (Fancc). Nor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Abu-Issa R,Eichele G,Youssoufian H

    更新日期:1999-07-15 00:00:00

  • Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival.

    abstract::Recent evidence suggests chronic myeloid leukemia (CML) stem cells are insensitive to kinase inhibitors and responsible for minimal residual disease in treated patients. We investigated whether CML stem cells, in a transgenic mouse model of CML-like disease or derived from patients, are dependent on Bcr-Abl. In the tr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-326843

    authors: Hamilton A,Helgason GV,Schemionek M,Zhang B,Myssina S,Allan EK,Nicolini FE,Müller-Tidow C,Bhatia R,Brunton VG,Koschmieder S,Holyoake TL

    更新日期:2012-02-09 00:00:00

  • Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease.

    abstract::We developed a risk score to predict event-free survival (EFS) after allogeneic hematopoietic cell transplantation for sickle cell disease. The study population (n = 1425) was randomly split into training (n = 1070) and validation (n = 355) cohorts. Risk factors were identified and validated via Cox regression models....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005687

    authors: Brazauskas R,Scigliuolo GM,Wang HL,Cappelli B,Ruggeri A,Fitzhugh CD,Hankins JS,Kanter J,Meerpohl JJ,Panepinto JA,Rondelli D,Shenoy S,Walters MC,Wagner JE,Tisdale JF,Gluckman E,Eapen M

    更新日期:2020-07-30 00:00:00

  • Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.

    abstract::We report a transfusion trial of platelets photochemically treated for pathogen inactivation using the synthetic psoralen amotosalen HCl. Patients with thrombocytopenia were randomly assigned to receive either photochemically treated (PCT) or conventional (control) platelets for up to 28 days. The primary end point wa...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood-2003-12-4443

    authors: McCullough J,Vesole DH,Benjamin RJ,Slichter SJ,Pineda A,Snyder E,Stadtmauer EA,Lopez-Plaza I,Coutre S,Strauss RG,Goodnough LT,Fridey JL,Raife T,Cable R,Murphy S,Howard F 4th,Davis K,Lin JS,Metzel P,Corash L,Koutso

    更新日期:2004-09-01 00:00:00

  • Recombinant prolylcarboxypeptidase activates plasma prekallikrein.

    abstract::The serine protease prolylcarboxypeptidase (PRCP), isolated from human umbilical vein endothelial cells (HUVECs), is a plasma prekallikrein (PK) activator. PRCP cDNA was cloned in pMT/BIP/V5-HIS-C, transfected into Schneider insect (S2) cells, and purified from serum-free media. Full-length recombinant PRCP (rPRCP) ac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2510

    authors: Shariat-Madar Z,Mahdi F,Schmaier AH

    更新日期:2004-06-15 00:00:00

  • Leukemia-associated antigens in ALL.

    abstract::A cytotoxic common ALL antiserum (CALLA) specific for leukemic cells of most patients with non-T-cel- acute lymphoblastic leukemia (ALL) and of some patients with chronic myelogenous leukemia (CML) in blast crisis has been reproducibly prepared using cell lines for absorption. CALLA reacts with leukemic cells of 110 o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pesando JM,Ritz J,Lazarus H,Costello SB,Sallan S,Schlossman SF

    更新日期:1979-12-01 00:00:00

  • Caloric restriction modulates Mcl-1 expression and sensitizes lymphomas to BH3 mimetic in mice.

    abstract::Caloric restriction (CR) is proposed to decrease tumorigenesis through a variety of mechanisms including effects on glycolysis. However, the understanding of how CR affects the response to cancer therapy is still rudimentary. Here, using the Eµ-Myc transgenic mouse model of B-cell lymphoma, we report that by reducing ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-01-478651

    authors: Meynet O,Zunino B,Happo L,Pradelli LA,Chiche J,Jacquin MA,Mondragón L,Tanti JF,Taillan B,Garnier G,Reverso-Meinietti J,Mounier N,Michiels JF,Michalak EM,Carles M,Scott CL,Ricci JE

    更新日期:2013-10-03 00:00:00

  • Human platelets exert cytotoxic effects on tumor cells.

    abstract::Monocytes are thought to play a role in host resistance to tumor cell growth in animals and humans. In addition, platelets are known to be involved in tumor metastases. To investigate the interaction of these two cell types and their effect on tumor cells, human monocytes and platelets were examined using an in vitro ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ibele GM,Kay NE,Johnson GJ,Jacob HS

    更新日期:1985-05-01 00:00:00

  • von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.

    abstract::Stroke is a leading cause of death and disability. The only therapy available is recombinant tissue plasminogen activator, but side effects limit its use. Platelets play a crucial role during stroke, and the inflammatory reaction promotes neurodegeneration. von Willebrand factor (VWF), an adhesion molecule for platele...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-213264

    authors: Zhao BQ,Chauhan AK,Canault M,Patten IS,Yang JJ,Dockal M,Scheiflinger F,Wagner DD

    更新日期:2009-10-08 00:00:00

  • Leukemia secondary to myeloproliferative neoplasms.

    abstract::Secondary acute myeloid leukemias (AMLs) evolving from an antecedent myeloproliferative neoplasm (MPN) are characterized by a unique set of cytogenetic and molecular features distinct from de novo AML. Given the high frequency of poor-risk cytogenetic and molecular features, malignant clones are frequently insensitive...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000943

    authors: Dunbar AJ,Rampal RK,Levine R

    更新日期:2020-07-02 00:00:00

  • In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs.

    abstract::Interleukin-6 (IL-6) administered as a single intravenous (IV) injection caused the following changes in the peripheral circulation of rats: (a) a biphasic neutrophilia with an initial peak at 1.5 hours and a second sustained wave of neutrophilia between four and 12 hours, (b) a mild lymphocytosis at 0.5 hours and a m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ulich TR,del Castillo J,Guo KZ

    更新日期:1989-01-01 00:00:00

  • T-cell leukemias with rearrangement of the gamma but not beta T-cell receptor genes.

    abstract::beta and gamma T cell receptor (TCR) gene configuration was studied in 12 patients with large granular lymphocyte T cell leukemia (LGL-leukemia). Both genes were found rearranged in ten cases. In the remaining two patients TCR beta was found in germline configuration. In one of them rearrangement of T cell-rearranging...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Foroni L,Matutes E,Foldi J,Morilla R,Rabbitts T,Luzzatto L,Catovsky D

    更新日期:1988-02-01 00:00:00